Mauro Goldbaum
About
In The Last Decade
Mauro Goldbaum
22 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 60
- Ophthalmology 1.3k
- Radiology, Nuclear Medicine and Imaging 970
- Molecular Biology 317
- Neurology 72
- Biomedical Engineering 40
Countries citing papers authored by Mauro Goldbaum
This map shows the geographic impact of Mauro Goldbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mauro Goldbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mauro Goldbaum more than expected).
Fields of papers citing papers by Mauro Goldbaum
This network shows the impact of papers produced by Mauro Goldbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mauro Goldbaum. The network helps show where Mauro Goldbaum may publish in the future.
Co-authorship network of co-authors of Mauro Goldbaum
This figure shows the co-authorship network connecting the top 25 collaborators of Mauro Goldbaum. A scholar is included among the top collaborators of Mauro Goldbaum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mauro Goldbaum. Mauro Goldbaum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 7 | |
| 3 | 8 | |
| 4 | 10 | |
| 5 | 18 | |
| 6 | 13 | |
| 7 | 21 | |
| 8 | 28 | |
| 9 | 17 | |
| 10 | 107 | |
| 11 | 16 | |
| 12 | 0 | |
| 13 | 12 | |
| 14 | A Phase II Randomized Double-Masked Trial of Pegaptanib, an Anti–Vascular Endothelial Growth Factor Aptamer, for Diabetic Macular Edema breakdown → | 454 |
| 15 | 106 | |
| 16 | 73 | |
| 17 | 4 | |
| 18 | 139 | |
| 19 | 0 | |
| 20 | 24 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.